- Instruments
- Reagents & Kits
- Genotyping Services
- Software and Services
Genotyping Market size is expected to be worth USD 12.3 billion in 2022 and is poised to grow at a 20.6% CAGR from 2023 to 2029. Genotyping is a laboratory process in which an individual's DNA is analyzed for specific nucleotides or bases to determine whether certain variants are present. Genotyping by sequencing also supports performing a comparative analysis of samples without knowing a reference genome. With the increasing incidence of genetic diseases, genotyping products are needed for the treatment. Hence, increasing adoption of genotyping products and rising awareness of personalized medicine is expected to support market growth in the coming years. Technological advancement in products for better results with maximum efficiency and precision will give the chance to critical players for making investments that will expand the Market. Nowadays, developed and developing regions are looking forward to advanced technology for the improvements to healthcare infrastructure would undoubtedly lead to the market growth rate in the forecasted period. The COVID-19 pandemic viewed a positive impact on the genotyping market, as the pandemic led to an increased demand for COVID-19 genotyping kits. Furthermore, the genotyping market will continuously grow with advancements in products and investment in better healthcare infrastructure.
Genotyping Market Key Developments:
- In May 2022, Neogen and Gencove launched InfiniSEEK - The First Whole Genome and Genotyping Sequencing Solution for Cattle Breeders
- In Sep 2020, Omixon launched Omnitype, a multiplex for NGS-based HLA genotyping
- In Jun 2021, The Centre for Aquaculture Technologies (CAT) and Neogen had a partnership plan to customize service by applying modern sequencing and genotyping technologies to aquaculture species, leveraging their complementary expertise
Genotyping Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
20.6%
Largest Market
Asia-Pacific
Fastest Growing Market
North America
Genotyping Market Dynamics
The major factors expected to be driving the genotyping assay market are technological advancements and the feasible prices of DNA sequencing. The growing incidence of genetic diseases and rising awareness of personalized medicine, the rising importance of genotyping in drug development and discoveries, and the increasing demand for bioinformatics solutions in data examination are also projected to promote market growth in the coming years. Also, the genotyping market is expanding due to the rising incidence of genetic disorders. With the advancement of PCR, capillary electrophoresis, sequencing, and microarray technologies for accurate and precise sequencing, high productivity. Moreover, these developments and advancements will create lucrative opportunities during the forecast period. The steady growth of the genotyping market is constrained by the high cost of instruments, kits & reagents uses in treatment.
North-America Got Significant Share
Genotyping Market
The Genotyping Market in North America is estimated to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase speedily. The increasing adoption of technologically advanced products, the existences of major pharmaceutical & biopharmaceutical companies, proactive government programs and funding, highly advanced and developed healthcare infrastructure, and the presence of key players in this region are the factor accountable for the high market share in the region. Europe is correspondingly anticipated to exhibit opportunities to enter the genotyping market with technological advancements and the growing pharma and biopharma sector in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The genotyping market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
Genotyping Market Segmentation
By Product Type
By Technology
- Real-time PCR
- Digital PCR
- Sequencing
- Microarrays
- Capillary Electrophoresis
- MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
- Other Technologies
By End User
- Diagnostic and Research Laboratories
- Pharmaceutical and Biopharmaceutical Companies
- Academic Institutes
- Others
Frequently Asked Questions
The genotyping market is projected to expand at a CAGR of 20.6% during the forecast period
Bio-Rad Laboratories Inc., Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., GE Healthcare Inc., Qiagen Inc., Neogen Corporation, Gencova Diagnostics, Hoffmann-La Roche Ltd.
North America is the fastest-growing region for genotyping market
| 1. Executive Summary |
| 2. Global Genotyping Market Introduction |
| 2.1. Global Genotyping Market Taxonomy |
| 2.2. Global Genotyping Market Definitions |
| 2.2.1. Product Type |
| 2.2.2. Technology Type |
| 2.2.3. Application Type |
| 2.2.4. End User |
| 2.2.5. Geography |
| 3. Global Genotyping Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Genotyping Market Dynamic Factors - Impact Analysis |
| 3.6. Global Genotyping Market Competition Landscape |
| 4. Global Genotyping Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Genotyping Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Instruments |
| 5.1.1. Analyzers |
| 5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Sequencers & Amplifier |
| 5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.2. Reagents & Kits |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Genotyping Services |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Software and Services |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Genotyping Market, By Technology Type, 2017 2021 and Forecast, 2022 2028 (Revenue, USD Mn) |
| 6.1. Real-time PCR |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Digital PCR |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Sequencing |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Microarrays |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Capillary Electrophoresis |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Other Technologies |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Global Genotyping Market Forecast, By Application, 2018 - 2022and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Agricultural Biotechnology |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmacogenomics |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Animal Genetics |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Diagnostic & Personalized Medicine |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Genotyping Market, By End User, 2017 2021 and Forecast, 2022 2028 (Revenue, USD Mn) |
| 8.1. Diagnostic and Research Laboratories |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Pharmaceutical and Biopharmaceutical Companies |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic Institutes |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Genotyping Market Forecast, By Region, 2018 - 2022and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Genotyping Market - Opportunity Analysis Index, By Product Type, Technology Type, Application Type, End User and Region, 2023 - 2029 |
| 10. North America Genotyping Market Analysis,2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Instruments |
| 10.1.1.1. Analyzers |
| 10.1.1.2. Sequencers & Amplifier |
| 10.1.2. Reagents & Kits |
| 10.1.3. Genotyping Services |
| 10.1.4. Software and Services |
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Real-time PCR |
| 10.2.2. Digital PCR |
| 10.2.3. Sequencing |
| 10.2.4. Microarrays |
| 10.2.5. Capillary Electrophoresis |
| 10.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 10.2.7. Other Technologies |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Agricultural Biotechnology |
| 10.3.2. Pharmacogenomics |
| 10.3.3. Animal Genetics |
| 10.3.4. Diagnostic & Personalized Medicine |
| 10.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Diagnostic and Research Laboratories |
| 10.4.2. Pharmaceutical and Biopharmaceutical Companies |
| 10.4.3. Academic Institutes |
| 10.4.4. Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Genotyping Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User and Country, 2023 - 2029 |
| 10.7. North America Genotyping Market Dynamics Trends |
| 11. Europe Genotyping Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Instruments |
| 11.1.1.1. Analyzers |
| 11.1.1.2. Sequencers & Amplifier |
| 11.1.2. Reagents & Kits |
| 11.1.3. Genotyping Services |
| 11.1.4. Software and Services |
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Real-time PCR |
| 11.2.2. Digital PCR |
| 11.2.3. Sequencing |
| 11.2.4. Microarrays |
| 11.2.5. Capillary Electrophoresis |
| 11.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 11.2.7. Other Technologies |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Agricultural Biotechnology |
| 11.3.2. Pharmacogenomics |
| 11.3.3. Animal Genetics |
| 11.3.4. Diagnostic & Personalized Medicine |
| 11.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Diagnostic and Research Laboratories |
| 11.4.2. Pharmaceutical and Biopharmaceutical Companies |
| 11.4.3. Academic Institutes |
| 11.4.4. Others |
| 11.5. Country Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Rest of Europe |
| 11.6. Europe Genotyping Market - Opportunity Analysis Index, By Product Type, Technology, Application Type, End User and Country, 2023 - 2029 |
| 11.7. Europe Genotyping Market Dynamics Trends |
| 12. Asia-Pacific Genotyping Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Instruments |
| 12.1.1.1. Analyzers |
| 12.1.1.2. Sequencers & Amplifier |
| 12.1.2. Reagents & Kits |
| 12.1.3. Genotyping Services |
| 12.1.4. Software and Services |
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Real-time PCR |
| 12.2.2. Digital PCR |
| 12.2.3. Sequencing |
| 12.2.4. Microarrays |
| 12.2.5. Capillary Electrophoresis |
| 12.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 12.2.7. Other Technologies |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Agricultural Biotechnology |
| 12.3.2. Pharmacogenomics |
| 12.3.3. Animal Genetics |
| 12.3.4. Diagnostic & Personalized Medicine |
| 12.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Diagnostic and Research Laboratories |
| 12.4.2. Pharmaceutical and Biopharmaceutical Companies |
| 12.4.3. Academic Institutes |
| 12.4.4. Others |
| 12.5. Country Analysis2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Genotyping Market - Opportunity Analysis Index, By Product Type, Technology Type, Application Type, End User and Country,2023 - 2029 |
| 12.7. Asia-Pacific Genotyping Market Dynamics Trends |
| 13. Latin America Genotyping Market Analysis,2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn) |
| 13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Instruments |
| 13.1.1.1. Analyzers |
| 13.1.1.2. Sequencers & Amplifier |
| 13.1.2. Reagents & Kits |
| 13.1.3. Genotyping Services |
| 13.1.4. Software and Services |
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Real-time PCR |
| 13.2.2. Digital PCR |
| 13.2.3. Sequencing |
| 13.2.4. Microarrays |
| 13.2.5. Capillary Electrophoresis |
| 13.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 13.2.7. Other Technologies |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Agricultural Biotechnology |
| 13.3.2. Pharmacogenomics |
| 13.3.3. Animal Genetics |
| 13.3.4. Diagnostic & Personalized Medicine |
| 13.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Diagnostic and Research Laboratories |
| 13.4.2. Pharmaceutical and Biopharmaceutical Companies |
| 13.4.3. Academic Institutes |
| 13.4.4. Others |
| 13.5. Country Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Rest of Latin America |
| 13.6. Latin America Genotyping Market - Opportunity Analysis Index, By Product Type, Technology, Application Type, End User and Country, 2023 - 2029 |
| 13.7. Latin America Genotyping Market Dynamics Trends |
| 14. Middle East and Africa Genotyping Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2018 - 2022and Forecast 2023 - 2029by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Instruments |
| 14.1.1.1. Analyzers |
| 14.1.1.2. Sequencers & Amplifier |
| 14.1.2. Reagents & Kits |
| 14.1.3. Genotyping Services |
| 14.1.4. Software and Services |
| 14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Real-time PCR |
| 14.2.2. Digital PCR |
| 14.2.3. Sequencing |
| 14.2.4. Microarrays |
| 14.2.5. Capillary Electrophoresis |
| 14.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) |
| 14.2.7. Other Technologies |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1. Agricultural Biotechnology |
| 14.3.2. Pharmacogenomics |
| 14.3.3. Animal Genetics |
| 14.3.4. Diagnostic & Personalized Medicine |
| 14.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies) |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Diagnostic and Research Laboratories |
| 14.4.2. Pharmaceutical and Biopharmaceutical Companies |
| 14.4.3. Academic Institutes |
| 14.4.4. Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA Genotyping Market - Opportunity Analysis Index, By Product Type, Technology Type, Application, End User and Country, 2023 - 2029 |
| 14.7. MEA Genotyping Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Bio-Rad Laboratories Inc. |
| 15.2.2. Illumina Inc. |
| 15.2.3. Agilent Technologies |
| 15.2.4. Thermo Fisher Scientific Inc. |
| 15.2.5. GE Healthcare Inc. |
| 15.2.6. Qiagen Inc. |
| 15.2.7. Neogen Corporation |
| 15.2.8. Gencova Diagnostics |
| 15.2.9. F. Hoffmann-La Roche Ltd. |
| 15.2.10. Fluidigm Corporation |
| 15.2.11. Danaher Corporation |
| 15.2.12. Eurofins Scientific |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Agilent Technologies
- Thermo Fisher Scientific Inc.
- GE Healthcare Inc.
- Qiagen Inc.
- Neogen Corporation
- Gencova Diagnostics
- Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Danaher Corporation
- Eurofins Scientific